Company
Harborside, Inc.
Headquarters: Oakland, CA, United States
CEO: Mr. Edward M. Schmults
Market Cap
$86.2 Million
USD as of Sept. 1, 2022
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Harborside Inc. engages in the cultivation, manufacture, distribution, wholesale, and retail of cannabis and cannabis products for the adult-use and medical markets in California. It owns and operates three retail dispensaries under the Harborside brand located in Oakland, San Jose, and San Leandro, California; and a dispensary under the Terpene Station brand name located in Eugene, Oregon, as well as manages and operates a dispensary under the Harborside brand under a management services agreement located in Desert Hot Springs, California. The company also operates approximately 47 acres of cultivation/production facility located in Salinas, California. It sells its products under the Harborside, Harborside Farms, Harborside Farms Reserve, and KEY brand names. Harborside Inc. has a strategic research agreement with Utah State University. The company was founded in 2006 and is headquartered in Oakland, California.
Top 1-year algo backtest: +298.72%
$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Harborside, Inc. has the following listings and related stock indices.
Stock: OTC: HBORF wb_incandescent
Stock: CSE: HBOR wb_incandescent